These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21298053)

  • 1. The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.
    Handel AE; Jarvis L; McLaughlin R; Fries A; Ebers GC; Ramagopalan SV
    PLoS One; 2011 Jan; 6(1):e14606. PubMed ID: 21298053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latitudinal variation in MS incidence in Scotland.
    McDonald JJ; Weller B; O'Neil M; Waters C; O'Riordan J;
    Mult Scler Relat Disord; 2019 Jul; 32():116-122. PubMed ID: 31112929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonality of admissions with multiple sclerosis in Scotland.
    Handel AE; Disanto G; Jarvis L; McLaughlin R; Fries A; Ebers GC; Ramagopalan SV
    Eur J Neurol; 2011 Aug; 18(8):1109-11. PubMed ID: 21749578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.
    Simpson S; Blizzard L; Otahal P; Van der Mei I; Taylor B
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1132-41. PubMed ID: 21478203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish Multiple Sclerosis Register.
    Kearns PKA; Paton M; O'Neill M; Waters C; Colville S; McDonald J; Young IJB; Pugh D; O'Riordan J; Weller B; MacDougall N; Clemens T; Dibben C; Wilson JF; Castro MC; Ascherio A; Chandran S; Connick P
    J Neurol; 2019 Oct; 266(10):2376-2386. PubMed ID: 31187189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and environmental factors and the distribution of multiple sclerosis in Europe.
    Handel AE; Handunnetthi L; Giovannoni G; Ebers GC; Ramagopalan SV
    Eur J Neurol; 2010 Sep; 17(9):1210-1214. PubMed ID: 20345929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and multiple sclerosis: evidence for latitudinal and temporal variation.
    O'Gorman C; Broadley SA
    J Neurol; 2014 Sep; 261(9):1677-83. PubMed ID: 24923244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geography of hospital admissions for multiple sclerosis in Greece.
    Dadouli K; Ntellas P; Anagnostopoulos L; Bonotis K; Dardiotis E; Hadjichristodoulou C
    Mult Scler Relat Disord; 2021 Apr; 49():102735. PubMed ID: 33444957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
    Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
    Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental factors in multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):3-9. PubMed ID: 24289836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latitude gradient for multiple sclerosis prevalence is established in the early life course.
    Sabel CE; Pearson JF; Mason DF; Willoughby E; Abernethy DA; Taylor BV
    Brain; 2021 Aug; 144(7):2038-2046. PubMed ID: 33704407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin D and latitude as environmental factors in multiple sclerosis].
    Niino M; Miyazaki Y; Fukazawa T; Kikuchi S
    Nihon Rinsho; 2014 Nov; 72(11):1924-9. PubMed ID: 25518372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
    Ascherio A; Munger KL
    Semin Neurol; 2016 Apr; 36(2):103-14. PubMed ID: 27116717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and multiple sclerosis hospital admissions in Scotland.
    Disanto G; Handel AE; Morahan JM; Deluca GC; Kimball SM; Hypponen E; Giovannoni G; Ebers GC; Ramagopalan SV
    QJM; 2011 Nov; 104(11):1001-3. PubMed ID: 21719427
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?
    Forbes RB; Wilson SV; Swingler RJ
    J Neurol; 1999 Nov; 246(11):1033-40. PubMed ID: 10631635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of birth and risk of multiple sclerosis in the Scottish population.
    Bayes HK; Weir CJ; O'Leary C
    Eur Neurol; 2010; 63(1):36-40. PubMed ID: 20029213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation.
    Carod-Artal FJ
    Mult Scler Relat Disord; 2021 Jan; 47():102657. PubMed ID: 33302230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in the incidence of multiple sclerosis: a systematic review.
    Alonso A; Hernán MA
    Neurology; 2008 Jul; 71(2):129-35. PubMed ID: 18606967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence and no latitude gradient of multiple sclerosis in Norway.
    Berg-Hansen P; Moen SM; Harbo HF; Celius EG
    Mult Scler; 2014 Nov; 20(13):1780-2. PubMed ID: 24603884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Environment and Lifestyle in Determining the Risk of Multiple Sclerosis.
    Hedström AK; Olsson T; Alfredsson L
    Curr Top Behav Neurosci; 2015; 26():87-104. PubMed ID: 25707369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.